Abstract:Healthcare is undergoing a transformation, and it is imperative to leverage new technologies to generate new data and support the advent of precision medicine (PM). Recent scientific breakthroughs and technological advancements have improved our understanding of disease pathogenesis and changed the way we diagnose and treat disease leading to more precise, predictable and powerful health care that is customized for the individual patient. Genetic, genomics, and epigenetic alterations appear to be contributing to different diseases. Deep clinical phenotyping, combined with advanced molecular phenotypic profiling, enables the construction of causal network models in which a genomic region is proposed to influence the levels of transcripts, proteins, and metabolites. Phenotypic analysis bears great importance to elucidat the pathophysiology of networks at the molecular and cellular level. Digital biomarkers (BMs) can have several applications beyond clinical trials in diagnostics—to identify patients affected by a disease or to guide treatment. Digital BMs present a big opportunity to measure clinical endpoints in a remote, objective and unbiased manner. However, the use of "omics" technologies and large sample sizes have generated massive amounts of data sets, and their analyses have become a major bottleneck requiring sophisticated computational and statistical methods. With the wealth of information for different diseases and its link to intrinsic biology, the challenge is now to turn the multi-parametric taxonomic classification of a disease into better clinical decision-making by more precisely defining a disease. As a result, the big data revolution has provided an opportunity to apply artificial intelligence (AI) and machine learning algorithms to this vast data set. The advancements in digital health opportunities have also arisen numerous questions and concerns on the future of healthcare practices in particular with what regards the reliability of AI diagnostic tools, the impact on clinical practice and vulnerability of algorithms. AI, machine learning algorithms, computational biology, and digital BMs will offer an opportunity to translate new data into actionable information thus, allowing earlier diagnosis and precise treatment options. A better understanding and cohesiveness of the different components of the knowledge network is a must to fully exploit the potential of it.

Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities

Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis

Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives

Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer

Toward multiomics-based next-generation diagnostics for precision medicine

Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare

Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations

Multi-omics profiling for health

Panomics for Precision Medicine

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine

Multi-omics profiling: the way toward precision medicine in metabolic diseases

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?

From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies

Clinical multi-omics strategies for the effective cancer management

Optimizing Clinical Workflow Using Precision Medicine and Advanced Data Analytics

Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology

Precision Medicine, AI, and the Future of Personalized Health Care

Are innovation and new technologies in precision medicine paving a new era in patients centric care?

Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future

Multi-omics approaches to studying gastrointestinal microbiome in the context of precision medicine and machine learning

Translational precision medicine: an industry perspective